Navigation Links
Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale
Date:10/24/2011

PINE BROOK, N.J., Oct. 24, 2011 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company focused on the development of antibody therapeutics, announced today that it is initiating a new clinical study to further demonstrate the safety of Anthim (ETI-204), the company's anti-toxin in late-stage development for prevention of disease and death from exposure to inhaled anthrax. The company also announced it has successfully manufactured Anthim at commercial scale. Anthim is an anti-toxin that significantly increases survival in anthrax-infected animals and is a promising candidate for the treatment of anthrax infection in people following a biowarfare attack.

(Logo: http://photos.prnewswire.com/prnh/20090420/NY01624LOGO)

The double blind, placebo-controlled dose-escalating study will include a total of 108 healthy human subjects and is designed to collect additional safety and pharmacokinetic (PK) data on Anthim.

"Our development timeline for Anthim is right on track, and this additional safety and PK data will further prove Anthim's utility as a strong candidate for addition to the Strategic National Stockpile," said Elizabeth Posillico, PhD, President and Chief Executive Officer of Elusys. "Anthim is demonstrating the potential to deliver significant therapeutic benefit to Americans infected with anthrax in a bioterrorism emergency."

Dr. Posillico will be presenting an update on Anthim's development program at the 10th Annual BIO Investor Forum in San Francisco on October 26.

"We have successfully manufactured Anthim at commercial scale, and look forward to finalizing our commercial production process to ensure the large-scale capacity needed to deliver high quality, consistent quantities of Anthim for the long term," added James Porter, Vice President of Development and Manufacturing at Elusys.

Anthrax is a life-threatening infectious disease caused by the bacterium Bacillus anthracis and remains one
'/>"/>

SOURCE Elusys Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Elusys Awarded $68 Million Contract to Develop Anthim for Intramuscular Pre- and Post-Exposure Prophylaxis of Anthrax Infection
2. Elusys Therapeutics and Lonza Extend Manufacturing Agreement for Anthim, a New Anthrax Treatment in Late-Stage Development
3. Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day
4. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
5. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CareFusion Initiates Class I Recall of EnVe Ventilators
8. Takeda Initiates Phase 3 Clinical Trial Program in the United States, Latin America, and Europe for Investigational Type 2 Diabetes Therapy TAK-875
9. ChemoCentryx Initiates Phase II Clinical Trial for CCX168, a Novel Small Molecule C5aR Antagonist for the Treatment of Vasculitis
10. Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast Cancer Patients
11. Adamas Pharmaceuticals Initiates a Phase 2/3 Clinical Study of ADS-5102 for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... TORONTO , May 22, 2013 /PRNewswire/ ... announced three presentations demonstrating the superiority of the AE37 ... Antigen Express, Inc. ( www.antigenexpress.com ). The presentations will ... Society of Clinical Oncology (ASCO) to be held in ... June 4, 2013. The presentation entitled " ...
(Date:5/22/2013)... -- Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a subsidiary ... announced on May 22 the actions that Ranbaxy ... conduct under prior management ( ... to support Ranbaxy in its efforts to address ... led to the investigations by the U.S. Department ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4
... meridianEMR Inc. announced today that it passed the milestone ... market-leading, ONC-ATCB 2011/2012 and CCHIT® certified, Urology-specific EHR. The ... practice of 28 Urology providers. With ... company added 85 new Urology providers in December 2010. ...
... and DUBLIN, Jan. 11, 2011 Amarin Corporation plc (Nasdaq: ... with a focus on cardiovascular disease, today announced that it ... Depositary Shares ("ADSs") at a price to the public of ... full of the underwriters, over-allotment option, the company sold a ...
Cached Medicine Technology:meridianEMR Reaches 1,000 Urology Providers and Celebrates the Best Sales Month in Company History 2Amarin Announces Successful Completion of Offering of American Depositary Shares 2Amarin Announces Successful Completion of Offering of American Depositary Shares 3
(Date:5/22/2013)... 22, 2013 Phelps Memorial Hospital Center ... Westchester Lung Nodule Center for individuals who would like ... care. Lung cancer is the deadliest form of cancer for ... the U.S. die from lung cancer than from breast, colon ... early detection increases survival rates. It is well established ...
(Date:5/22/2013)... Space Girl Organics is excited to announce ... I Talk to Strangers Miracle Run/Walk . The 5K ... Park in Cocoa, FL. The event aims to “create miracles” ... movement. , As a sponsor, Space Girl Organics is organizing ... event. Additionally, they are providing bananas for runners and donating ...
(Date:5/22/2013)... May 22, 2013 Unknown to the citizens ... at 30 mph. Minutes before it struck, the city’s ... nearing threat. This gave them time to reach safety and ... is proud to provide a product that will increase ... Wheelock SAFEPATH® SP40S Emergency Evacuation System provides employees ...
(Date:5/22/2013)... the aftermath of this week,s deadly tornado, many people in ... relatives, but also their pets. Finding a missing ... to temporary housing can be stressful, but experts from the ... to ease that transition. One smart step: Always carry ... used to help identify any animals displaced during an emergency. ...
(Date:5/22/2013)... Massachusetts General Hospital (MGH) one of the nation,s ... rated the training they had received in addiction and ... numbers felt unprepared to diagnose or treat such disorders, ... to the findings, recently published online in the journal ... training in addiction medicine. , "Our residents estimated ...
Breaking Medicine News(10 mins):Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2Health News:Simple Steps Can Protect Pets in Weather Disasters 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4
... Britons are packed with dust mites, fungus and skin scales.// ... to contain up to 20,000 live house dust mites in addition ... unwashed duvet revealed over an ounce and a half of debris ... addition it was found that more than four in ten people ...
... in Melbourne Australia have performed the first incompatible blood ... Royal Melbourne hospital have performed a kidney transplant despite ... was explained that Davorin Gelemanovic, 24, who is of ... from his father, who has type A blood. Mr ...
... Tata group, the Essar group and the Jindal group ... that would ensure medicare for people leaving Below Poverty ... first public-private partnership, the Sarva Swasthya Mission trust is ... major corporate groups, an official release said here today ...
... well as a good balanced diet can avert strokes in ... 1993 with over 37,600 women as participants//. ,All ... rated on a "health index score." The scores ranged from ... the woman. ,The women were followed for a ...
... of India have accorded sanction to the Karnataka government to ... from this academic year, the state assembly was informed today. ... in Belgaum and Mandya, Medical Education Minister V S Acharya ... MCI has approved an intake of 100 students in each ...
... The death toll in Dooars and Terai region of North ... and a half months till yesterday. // ,Chief ... malaria deaths were reported in Dooars region of Jalpaiguri district, ... days in the area., ,In the Terai region at ...
Cached Medicine News:Health News:Dust mites use Duvets as their Haven 2
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Leica surgical micro...
... Archive Manage and ... ,Introducing Optronics DVMR- office, the ... designed for the physician's office ... a variety of high-resolution cameras ...
Medicine Products: